ON THE BALLOT
Prohibitionists fail to remove cannabis legalization from ballot in Missouri
Missouri is due to vote on adult-use cannabis legalization in less than 10 weeks, prompting a lawsuit to remove the choice from the ballot which has been dismissed, per Marijuana Moment.
The vote has been brought to the ballot by the Legalize Missouri 2022 campaign and if passed it would:
- Legalize possession for adults over 21 and over.
- Allow home cultivation of up to 18 plants total
- Automatic expungements for non-violent cannabis crimes, paid for by cannabis taxes.
- Microbusinesses, low income and those affected by cannabis prohibition would be prioritized for licenses.
“We are thrilled that Missourians will have the opportunity to pass Amendment 3 in November, which will allow law enforcement to better focus on violent crime, while bringing millions in new revenue to Missouri.” said John Payne, Legal Missouri 2022 Campaign Manager.
Enjoy Cannabis Daily each morning at 7 a.m.
NEW LEADER?
Canada’s market leading share in German imports waning
Canada has remained the largest importer to Germany’s small but important cannabis industry, but that leading share is beginning to wane, reports MJBiz Daily.
In the first half of the year, Germany imported a record amount of cannabis, with it on track to surpass 2021’s total. Germany now has imports from companies in Denmark, the Netherlands and Portugal who are taking market share from Canada who currently import
Canada has accounted for upward of 38% of all of Germany’s medical cannabis imports since 2017, according to a report by Der Spiegel newspaper, citing government data.
SA TO EU
Europe’s medical cannabis changes is good news for South Africa
Ever more progressive cannabis laws in Europe are good for business in South Africa, per Bloomberg.
With the right climate, infrastructure and cheap land, South Africa has been attracting investment in its cannabis industry with Prohibition Partners predicting the country’s cannabis industry is predicted to be worth 27 billion rand ($1.6 billion) by 2023. SafriCanna has already sold all of its output for next year in advance.
SafriCanna is one of only a few African companies to have met the European Union’s strict GMP standards, allowing it to export cannabis flowers as an active pharmaceutical ingredient to Europe.
